REFERENCES
- Bar-Meir S, Lerner E, Conn HO. Analysis of ascitic fluid in cirrhosis. Dig Dis Sci 1979, 24, 136–144
- Parè P, Talbot J, Hoefs JC. Serum-ascites albumin concentration gradient: a physiologic approach of the differential diagnosis of ascites. Gastroenterology 1983, 85, 240–244
- Rector WG Jr, Reynolds TB. Superiority of the serum-ascites albumin difference over the ascites total protein concentration in separation of transudative and exudative ascites. Am J Med 1984, 77, 83–85
- Boyer TD, Kahn AN, Reynolds TB. Diagnostic value of ascitic fluid lactic dehydrogenase, protein and WBC levels. Arch Intern Med 1978, 138, 1103–1105
- Scholmerich J, Volk BA, Kottgen E, et al. Fibronectin concentration in ascites differentiates between malignant and non-malignant ascites. Gastroenterology 1984, 87, 1160–1164
- Colli A, Buccino G, Cocciolo M, et al. Diagnostic accuracy of fibronectin in the differential diagnosis of ascites. Cancer 1986, 58, 2489–2493
- Deverbizier G, Beauchant M, Chapron A, et al. Fibronectin, a market for malignant ascites. Lancet 1984, 2, 1104
- Jungst D, Gerbes AL, Martin R, Paumgarten G. Values of ascitic lipids in the differentiation between cirrhotic and malignant ascites. Hepatology 1986, 6, 239–243
- Runyon BA. Elevated ascitic fluid fibronectin concentration. A non-specific finding. J Hepatol 1986, 3, 219–222
- Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med 1986, 146, 2259–2261
- Gressner AM. Wallraff P. Immunoturbidimetric measurement of clod insoluble globulin with reference to a laser nephelometric assay. J Clin Chem Biochem 1981, 19, 1213–1215
- Loewenstein MS, Rittgers RA, Feinerman AE, et al. Carcinoembryonic antigen assay of ascites and detection of malignancy. Ann Intern Med 1978, 88, 635–638
- Sampliner RE, Iber FL. High protein ascites in patients with uncomplicated hepatic cirrhosis. Am J Med 1974, 267, 275–279
- Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988, 8, 1104–1109
- Wrobleski F, Wroblesli R. The clinical significance of lactic dehydrogenase activity of serous effusions. Ann Intern Med 1958, 48, 813–822
- Kirkebi K, Prydz H. Lactic dehydrogenase activity in pleural and peritoneal effusions. Scand J Clin Lab Invest 1959, 11, 185–189
- Smith HS, Riggs JL, Mosesson MW. Production of fibronectin by human epithelial cells in culture. Cancer Res 1979, 39, 4138–4144
- Runyon BA, Hoefs JC. Ascitic fluid chemical analysis before, during and after spontaneous bacterial peritonitis. Hepatology 1985, 5, 257–259
- Villar M, Garcia-Bragado F, Vilardell M, et al. Fibronectin concentration in ascites does not differentiate between malignant and non-malignant ascites. Gastroenterology 1988, 94, 556
- Booth SN, Lakin G, Dykes PW, et al. Cancer associated proteins in effusion fluids. J Clinic Pathol 1977, 30, 537–540
- Abelev GI. Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Adv Cancer Res 1971, 14, 295–358
- Wepsic HT, Kirkpatrick A. Alpha-fetoprotein and its relevance to human disease. Gastroenterology 1979, 77, 787–796
- Prieto M, Gomez-Lechon MJ, Hoyos M, Castell J, Carrasco D, Berenguer J. Diagnosis of malignant ascites. Comparison of ascitic fibronectin, cholesterol, and serum-ascites albumin difference. Dig Dis Sci 1988, 33, 833–838